Back to Authors

Banacloche, Juan Gea

Mayo Clinic

Division of Infectious Diseases, Mayo Clinic in Arizona, Phoenix, Arizona, USA.

Citations 1

Coccidioidomycosis in Patients Treated With Ruxolitinib
Kusne, Yael , Kimes, Kathryn E., Feller, Fionna , Patron, Roberto L. , Gea‐Banacloche, Juan , Blair, Janis E. , Vikram, Holenarasipur R. , Ampel, Neil M. , Feller, Fionna F, Patron, Roberto, Banacloche, Juan Gea, Vikram, Holenarasipur R.

Open Forum Infectious Diseases | June 10, 2020 | Volume: 7 | Issue: 6 | Pages: No page available

10.1093/ofid/ofaa167 Get It

Abstract We report 8 cases of coccidioidomycosis associated with ruxolitinib treatment. Among 135 patients living in the coccidioidal-endemic region receiving ruxolitinib, 5 cases were diagnosed after starting and 4 had extrathoracic dissemination. Periodic serological screening while on ruxolitinib is warranted for patients residing in the coccidioidal-endemic region.